The 6th Annual NHLBI Progenitor Cell Translational Consortium (PCTC) 2023 is dedicated to developments in the study of progenitor cells biology towards application to lung, heart and blood diseases with a focus on the use of progenitor cell-based disease models to understand disease mechanisms and to develop therapies.
The 6th Annual NHLBI Progenitor Cell Translational Consortium (PCTC) 2023 covers topics such as:
The 6th Annual NHLBI Progenitor Cell Translational Consortium (PCTC) 2023 brings together researchers, practitioners and physicians.